Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy.

Details

Language :

English

ISSN :

20414889

Volume :

14

Issue :

10

Database :

Complementary Index

Journal :

Cell Death & Disease

Publication Type :

Academic Journal

Accession number :

173653213

Full Text :

https://doi.org/10.1038/s41419-023-06230-z